Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ISONIAZID CRS (100 MG)

ISONIAZID CRS (100 MG)

54-85-3

DISCOVER
Irbesartan

Irbesartan

138402-11-6

DISCOVER
Idarubicine HCl

Idarubicine HCl

58957-92-9

DISCOVER
ISOPRENALINE HYDROCHLORIDE CRS (50 MG)

ISOPRENALINE HYDROCHLORIDE CRS (50 MG)

51-30-9

DISCOVER
ISOPRENALINE SULFATE CRS (510MG)

ISOPRENALINE SULFATE CRS (510MG)

6700-39-6

DISCOVER
ISOPROPYL HEXADECANOATE CRS (100 MG)

ISOPROPYL HEXADECANOATE CRS (100 MG)

142-91-6

DISCOVER
Isoxsuprine HCl

Isoxsuprine HCl

579-56-6

DISCOVER
ISOPROPYL TETRADECANOATE CRS (2 ML)

ISOPROPYL TETRADECANOATE CRS (2 ML)

110-27-0

DISCOVER
Isopropyl tetradecanoate CRS,2mL

Isopropyl tetradecanoate CRS,2mL

110-27-0

DISCOVER
Isopropyl tetradecanoate CRS,2mL

Isopropyl tetradecanoate CRS,2mL

110-27-0

DISCOVER
ISOSORBIDE DINITRATE CRS (350MG)

ISOSORBIDE DINITRATE CRS (350MG)

87-33-2

DISCOVER
ISOSORBIDE MONONITRATE CRS (150 MG)

ISOSORBIDE MONONITRATE CRS (150 MG)

16051-77-7

DISCOVER